title: [Psychopharmacotherapy of mood disorders during pregnancy and lactation].
abstract: The aim of the second part of our work associated with psychopharmacotherapy during pregnancy and lactation is to present current guidelines of expert-groups concerning the rules of treating affective disorders and actual data about the spreading of these disorders pre- and perinatal effects of drugs used, the classification of antidepressants and mood stabilizers according to FDA and the safety of these medications for the breast fed newborn.
authors.affiliation: Klinika Psychiatrii AM, Lublinie.
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Szajer
authors.forename: Hanna
authors.initials: H
authors.lastname: Karakuła
authors.forename: Justyna
authors.initials: J
authors.lastname: Pawezka
authors.forename: Anna
authors.initials: A
authors.lastname: Grzywa
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Przywara
authors.forename: Adam
authors.initials: A
authors.lastname: Gut
mesh_terms: D001942:Breast Feeding; D005260:Female; D047109:Fetal Development / Q000187:drug effects*; D006801:Humans; D007229:Infant Welfare; D007231:Infant, Newborn; D007774:Lactation / Q000187:drug effects*; D008429:Maternal Welfare; D019964:Mood Disorders / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000523:psychology; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors
chemical_list: D011619:Psychotropic Drugs